某心血管病医院门诊抗幽门螺杆菌药物使用分析  

Analysis of Prescriptions for Anti-H.pylori in Outpatient Department in A Cardiovascular Hospital

作　　者：张新乐[1] 杨玉玲[1] 院江丽 王文文[1] ZHANG Xinle;YANG Yuling;YUAN Jiangli;WANG Wenwen(Department of Pharmacy,The 7th People’s Hospital of Zhengzhou,Zhengzhou Henan 450016,China)

机构地区：[1]郑州市第七人民医院药学部,河南郑州450016

出　　处：《临床研究》2020年第5期16-17,共2页Clinical Research

摘　　要：目的了解门诊幽门螺杆菌感染患者药物使用情况,为临床合理用药提供参考依据。方法对郑州市第七人民医院2018年7月-2018年12月期间门诊处方进行调查和统计分析。结果铋剂四联疗法临床使用最多,阿莫西林胶囊、泮托拉唑肠溶胶囊、胶体果胶铋胶囊使用率比较高,分别为96%、92%、90%。结论本院门诊抗幽门螺杆菌药物使用基本合理,应加强个体化治疗。Objective To understand the drug use of patients with helicobacter pylori infection in outpatient clinic,and to provide reference for rational drug use in clinical practice.Methods An investigation and statistical analysis were conducted on outpatient prescriptions of the 7th People’s Hospital of Zhengzhou from July 2018 to December 2018.Results Quadruple therapy with bismuth is the most commonly used,and amoxicillin capsule,pantoprazole enteric capsule and colloidal pectin bismuth capsule were used at a high rate of 96%,92%,and 90%,respectively.Conclusion The use of anti-helicobacter pylori drugs in the outpatient department of our hospital is basically reasonable and individual treatment should be strengthened.

关 键 词：幽门螺杆菌感染 处方分析 合理用药 

分 类 号：R573[医药卫生—消化系统]